Sparhawk Laboratories Inc. is recalling approximately 7,228 vials of Atropine Sulfate 1/120 Injectable Solution (0.54 mg/mL) because the medication failed stability testing. Testing at the 12-month interval showed the potency of the drug was lower than required standards. This recall affects 100-ml vials of this prescription veterinary medication that were distributed to Missouri and Ohio.
The low potency means the medication may not provide the intended therapeutic effect when administered to an animal, which could lead to inadequate treatment of the condition for which the atropine was prescribed.
Drug recall refund and guidance
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response